It is a pharma private limited company based in Kolhapur, Maharashtra, India, established in 2015.
2015 | Kolhapur, Maharashtra, India | ActiveLysten Global Pharmaceuticals Private Limited, a active private limited company, was established on 31 July 2015 in Kolhapur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239PN2015PTC156013. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 36 professional, Its leadership includes Vikas Lalasaheb Patil (Director), Nitin Parshram Jadhav (Director), Sachin Lalasaheb Patil (Director). Past directors included Sneha Bahubali Borgave, Vikas Lalasaheb Patil, Nitin Parshram Jadhav. It holds no open charges and ₹5.50 M settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at S. No. 235, Flat No. 5, Visava Apartment B Ward, Hanuman Nagar, Kolhapur, Maharashtra, 416007.
U24239PN2015PTC156013
156013
31 July 2015
₹1.00 M
₹1.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Lysten Global Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikas Lalasaheb Patil | Director | 13 Jul 2016 | Current |
| Nitin Parshram Jadhav | Director | 31 Jul 2015 | Current |
| Sachin Lalasaheb Patil | Director | 31 Jul 2015 | Current |
| Vijay Shamrao Patil | Director | 04 Nov 2015 | Current |
| Shilpa Nitin Jadhav | Director | 21 Nov 2015 | Current |
| Bahubali Kumar Borgave | Director | 13 Jul 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2016 | Past |
| Pramod Abcsdd | Director | 15 Jul 2021 | Past |
| Pramod Abcsdd | Director | 23 Oct 2015 | Past |
| Pramod Abcsdd | Director | 15 Jul 2021 | Past |
| Pramod Abcsdd | Additional Director | 11 Jan 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lysten Global Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 21.4% decrease. The company also saw a substantial improvement in profitability, with a 54.79% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.35%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Lysten Global Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹5,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2017 | Indian Bank | ₹5.50 M | Satisfied |
Explore comprehensive loan charge details -
Lysten Global Pharmaceuticals has a workforce of 36 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lysten Global Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lysten Global Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Lysten Global Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
A charge registered on 31 Jan 2017 via Charge ID 100120028 with Indian Bank was fully satisfied on 16 May 2023. was recorded as a recent event.
Lysten Global Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Pune. was recorded as a recent event.
Progress on A charge with Indian Bank amounted to Rs. 5.50 M with Charge ID 100120028 was registered on 31 Jan 2017. was documented.
Progress on Vikas Lalasaheb Patil was appointed as a Director was appointed as a Director on 13 Jul 2016 & has been associated with this company since 9 years 5 months . was documented.
The activity Bahubali Kumar Borgave was appointed as a Director was appointed as a Director on 13 Jul 2016 & has been associated with this company since 9 years 5 months . was completed.
The CIN of Lysten Global Pharmaceuticals Private Limited is U24239PN2015PTC156013.
Lysten Global Pharmaceuticals Private Limited is headquartered at S. No. 235, Flat No. 5, Visava Apartment B Ward, Hanuman Nagar, Kolhapur, Maharashtra, 416007.
Lysten Global Pharmaceuticals Private Limited was incorporated on 31 July 2015.
The current directors of Lysten Global Pharmaceuticals Private Limited are
The primary industry of Lysten Global Pharmaceuticals Private Limited is Trade.
Lysten Global Pharmaceuticals Private Limited is unlisted.
The authorized capital of Lysten Global Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Lysten Global Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX